CD8A and neoplasm: The active sPD-L1 fragment generated by ADAM10 and ADAM17 cleavage of mPD-L1 was found to attenuate the killing of tumor cells by CD8+ T cells, revealing a novel mechanism of resistance to anti-PD-(L)1 antibodies (114).